MedPath

A study to see the additive epidural analgesic effect of two drugs dexmedetomidine & fentanyl

Phase 1
Conditions
Health Condition 1: G890- Central pain syndrome
Registration Number
CTRI/2020/05/025233
Lead Sponsor
Ptjnm medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients undergoing lower thoracic (below T8)& lumbosacral spine fixation

Exclusion Criteria

1.Refuse to participate, 2.chronic pain syndrome, 3. cardiac diseases,4.hematological disease, 5.psychiatric disease,6.allergy to local anaesthetic, 7.upper thoracic & 8.cervical spine surgery,9.tubercular spine

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analgesia using VISUAL ANALOG SCORE.Timepoint: 1year
Secondary Outcome Measures
NameTimeMethod
Patients satisfaction <br/ ><br>Ramsay sedation score <br/ ><br>Heart rate <br/ ><br>Blood pressure <br/ ><br>Side effectsTimepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath